BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37272061)

  • 1. Clinicopathological Characteristics of Autoimmune-Like Hepatitis Induced by COVID-19 mRNA Vaccine (Pfizer-BioNTech, BNT162b2): A Case Report and Literature Review.
    Kim JH; Chae HB; Woo S; Song MS; Kim HJ; Woo CG
    Int J Surg Pathol; 2023 Sep; 31(6):1156-1162. PubMed ID: 37272061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
    Ueno M; Takabatake H; Itakura J; Fujita R; Kayahara T; Morimoto Y; Notohara K; Mizuno M
    Clin J Gastroenterol; 2023 Aug; 16(4):554-558. PubMed ID: 37029249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.
    Suzuki M; Sekiguchi Y; Sasaki M; Inaba S; Oyama S; Inoue Y; Warabi M; Ohashi K; Inoshita S
    Intern Med; 2022; 61(19):2925-2929. PubMed ID: 36184535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.
    Efe C; Kulkarni AV; Terziroli Beretta-Piccoli B; Magro B; Stättermayer A; Cengiz M; Clayton-Chubb D; Lammert C; Bernsmeier C; Gül Ö; la Tijera FH; Anders M; Lytvyak E; Akın M; Purnak T; Liberal R; Peralta M; Ebik B; Duman S; Demir N; Balaban Y; Urzua Á; Contreras F; Venturelli MG; Bilgiç Y; Medina A; Girala M; Günşar F; Londoño MC; Androutsakos T; Kisch A; Yurci A; Güzelbulut F; Çağın YF; Avcı E; Akyıldız M; Dindar-Demiray EK; Harputluoğlu M; Kumar R; Satapathy SK; Mendizabal M; Silva M; Fagiuoli S; Roberts SK; Soylu NK; Idilman R; Yoshida EM; Montano-Loza AJ; Dalekos GN; Ridruejo E; Schiano TD; Wahlin S
    Hepatology; 2022 Dec; 76(6):1576-1586. PubMed ID: 35567545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination.
    Mahalingham A; Duckworth A; Griffiths WJH
    Transpl Immunol; 2022 Jun; 72():101600. PubMed ID: 35390478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.
    Lasagna A; Lenti MV; Cassaniti I; Sacchi P
    Immunotherapy; 2022 Aug; 14(12):915-925. PubMed ID: 35694999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Characteristics of Inflammatory Myositis Induced by COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report.
    Kim JH; Kim JH; Woo CG
    J Korean Med Sci; 2022 Mar; 37(11):e91. PubMed ID: 35315602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
    Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
    Al-Rasbi S; Al-Maqbali JS; Al-Farsi R; Al Shukaili MA; Al-Riyami MH; Al Falahi Z; Al Farhan H; Al Alawi AM
    Am J Case Rep; 2022 Feb; 23():e934399. PubMed ID: 35173141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
    J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review.
    Chahed F; Ben Fadhel N; Ben Romdhane H; Youssef M; Ben Hammouda S; Chaabane A; Aouam K; Ben Fredj N
    Br J Clin Pharmacol; 2023 Feb; 89(2):536-540. PubMed ID: 35434826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech).
    Akiyama Y; Inagaki T; Morioka S; Kusano E; Ohmagari N
    Intern Med; 2023 Jul; 62(13):2013-2017. PubMed ID: 37081683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.
    Kim Y; Kang J; Lee SG; Kim GT
    Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine.
    Nomura J; Seki M; Abe S; Kobayashi T; Okitsu Y; Fukuhara N; Takahashi S; Harigae H; Kameoka J
    Hum Vaccin Immunother; 2023 Dec; 19(1):2165381. PubMed ID: 36625832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.